Journal
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 31, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2020.127712
Keywords
Tropomyosin receptor kinases; Anticancer; Design and synthesis; Molecular docking
Categories
Funding
- National First-class Discipline Program of Food Science and Technology [JUFSTR20180101]
- National Natural Science Foundation of China [21305051]
Ask authors/readers for more resources
Novel pyrazolo[1,5-a]pyrimidine derivatives were synthesized as Trk inhibitors, showing potent inhibitory activities against Trk. Particularly, compounds 8a, 8f, 9a, 9b, and 9f exhibited significant inhibitory potency against Trk with IC50 values < 5 nM.
Tropomyosin receptor kinases (Trks), a transmembrane receptor tyrosine kinases, have attracted more and more attention as a drug target. Here we reported the structure-based synthesis and biological evaluation of novel pyrazolo[1,5-a]pyrimidine derivatives as Trk inhibitors, which exhibited potent Trk inhibitory activities. Particularly, compounds 8a, 8f, 9a, 9b and 9f (IC50 < 5 nM) showed significant inhibitory potency against Trk.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available